Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)

Clinical trial NCT07569198 · RECRUITING

Trial details

NCT number: NCT07569198
Sponsor: Joshua Rosenblat
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Borderline Personality Disorder (BPD)Treatment-Resistant Major Depressive Disorder Treatment-resistant Bipolar Depression Major Depressive Disorder (MDD)Bipolar Disorder (BD)Bipolar Disorder I or II Suicidal Ideation

Start date: 2026-07-16
Primary completion: 2029-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.